Astodrimer sodium, also known by its research name SPL7013, is a dendrimer-based microbicide that has garnered attention for its potential in preventing and treating
sexually transmitted infections (STIs). Derived from a class of compounds known as dendrimers, Astodrimer sodium is a synthetic, star-shaped macromolecule with a branching, tree-like structure. This distinctive architecture is integral to its mechanism of action, which hinges on its ability to interact with and disrupt pathogens at a molecular level.
The primary mechanism of Astodrimer sodium involves the inhibition of viral and bacterial attachment and entry into host cells. The dendrimer structure is designed to interact with the surface proteins of pathogens, thereby preventing them from binding to the receptors on the host cell surface. For instance, in the case of HIV, Astodrimer sodium targets the viral envelope glycoproteins, specifically gp120. By binding to
gp120, it blocks the interaction between the virus and the CD4 receptors on T-cells, hindering the virus's ability to fuse with and enter the host cell.
Moreover, Astodrimer sodium exhibits broad-spectrum antimicrobial activity. It acts against a range of viruses, including herpes simplex virus (HSV) and human papillomavirus (HPV), as well as bacteria like Neisseria gonorrhoeae, which causes
gonorrhea. The antiviral action extends to enveloped viruses, where Astodrimer sodium disrupts the lipid bilayer of the viral envelope, leading to the inactivation of the virus. This disruption is facilitated by the dendrimer's surface groups, which interact with the lipid components and destabilize the envelope structure.
In addition to its direct antimicrobial activity, Astodrimer sodium also has a physical blocking mechanism. When formulated into a gel or cream, it creates a barrier on mucosal surfaces, providing a protective layer that can reduce the transmission of pathogens during sexual contact. This barrier function is particularly beneficial in preventing the spread of STIs when applied topically to genital or rectal areas.
Another significant aspect of Astodrimer sodium's mechanism is its ability to modulate the host's immune response. Research suggests that it can reduce
inflammation and the subsequent immune activation that often accompanies
viral and bacterial infections. By mitigating inflammation, Astodrimer sodium not only helps in reducing tissue damage but also in decreasing the likelihood of secondary infections or complications.
Astodrimer sodium's safety profile is also noteworthy. Its high molecular weight and dendrimer structure limit systemic absorption, which minimizes the likelihood of systemic side effects. This makes it a favorable option for topical use, where localized action is desired without significant systemic exposure.
In summary, the mechanism of Astodrimer sodium involves multiple facets: it prevents the attachment and entry of pathogens into host cells, disrupts the structural integrity of viruses and bacteria, forms a physical barrier to block pathogen transmission, and modulates the host immune response to reduce inflammation. These combined actions make Astodrimer sodium a promising microbicide for the prevention and treatment of sexually transmitted infections, offering a multifaceted approach to combating a range of pathogens with a favorable safety profile.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


